Fidelity Investments’s Acceleron Pharma XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $357M | Sell |
|
|||||
|
2021
Q2 | $352M | Sell |
|
|||||
|
2021
Q1 | $505M | Sell |
|
|||||
|
2020
Q4 | $599M | Sell |
|
|||||
|
2020
Q3 | $657M | Sell |
|
|||||
|
2020
Q2 | $731M | Sell |
|
|||||
|
2020
Q1 | $719M | Buy |
|
|||||
|
2019
Q4 | $422M | Buy |
|
|||||
|
2019
Q3 | $235M | Sell |
|
|||||
|
2019
Q2 | $265M | Sell |
|
|||||
|
2019
Q1 | $343M | Buy |
|
|||||
|
2018
Q4 | $302M | Buy |
|
|||||
|
2018
Q3 | $395M | Buy |
|
|||||
|
2018
Q2 | $214M | Sell |
|
|||||
|
2018
Q1 | $202M | Buy |
|
|||||
|
2017
Q4 | $217M | Buy |
|
|||||
|
2017
Q3 | $139M | Sell |
|
|||||
|
2017
Q2 | $144M | Sell |
|
|||||
|
2017
Q1 | $128M | Sell |
|
|||||
|
2016
Q4 | $134M | Sell |
|
|||||
|
2016
Q3 | $204M | Buy |
|
|||||
|
2016
Q2 | $189M | Buy |
|
|||||
|
2016
Q1 | $147M | Buy |
|
|||||
|
2015
Q4 | $243M | Buy |
|
|||||
|
2015
Q3 | $123M | Buy |
|
|||||
|
2015
Q2 | $156M | Buy |
|
|||||
|
2015
Q1 | $186M | Buy |
|
|||||
|
2014
Q4 | $188M | Buy |
|
|||||
|
2014
Q3 | $144M | Buy |
|
|||||
|
2014
Q2 | $160M | Buy |
|
|||||
|
2014
Q1 | $89.8M | Buy |
|
|||||
|
2013
Q4 | $71.4M | Buy |
|